Abstract
In 1963, Easson and Russell<sup>27</sup>reported that 13% of 822 patients with Hodgkin's disease were alive at 15 years and were presumably cured by radiotherapy. Curative therapy became the primary clinical objective in Hodgkin's disease, replacing symptomatic amelioration. Improved clinical staging and histological classification facilitated therapeutic management. In a report by Peters et al,<sup>28</sup>of 1,131 patients treated with radiotherapy from 1931 to 1969, the five-year survival rate was 43%. During the period from 1965 to 1969, with the completion of five years of observation of 64 patients, the survival was 59%; it is stated that 40% of these patients were in stages I and II of the disease. The radiotherapy center at Stanford<sup>29</sup>reports 275 patients with Hodgkin's disease, of whom 54 have completed five years of observation. The five-year survival was 73%; however, 80% of the patients were in stages I and II of the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
